ST. PAUL, Minn.—-EnteroMedics Inc. , the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that it expects study results from ongoing clinical trials of the company’s VBLOC™ vagal blocking therapy to be presented at 3:00 PM ET on June 19, 2008 during a plenary session of the 25th annual meeting of the American …
More: continued here